Novartis Investigative Site

Caen Cedex9 14033

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Cushing's Disease

Studies at this site

• Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease — Completed
• Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma. — Completed